Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 19.43%11.17B | -6.73%9.35B | 19.04%2.71B | 1.54%2.32B | -6.97%2.46B | -33.94%1.87B | -4.02%10.03B | -12.04%2.28B | -18.66%2.28B | 7.18%2.64B |
| Cost of revenue | 0.38%6.8B | 3.23%6.78B | 25.72%1.97B | -5.73%1.5B | 18.92%1.86B | -21.32%1.46B | 11.25%6.56B | -3.30%1.56B | 6.27%1.59B | 13.65%1.56B |
| Gross profit | 69.54%4.37B | -25.60%2.58B | 4.38%743.62M | 18.05%823.63M | -44.43%600.21M | -57.92%409.94M | -23.84%3.46B | -26.59%712.42M | -46.95%697.67M | -0.99%1.08B |
| Operating expense | 13.50%3.43B | -7.13%3.02B | -3.51%723.07M | -3.56%776.73M | -1.42%773.72M | -18.17%746.16M | 5.51%3.25B | -12.72%749.36M | 0.67%805.42M | 7.40%784.87M |
| Staff costs | 22.72%1.42B | 4.85%1.16B | ---- | ---- | ---- | ---- | -3.43%1.1B | ---- | ---- | ---- |
| Selling and administrative expenses | 27.02%273.27M | -39.37%215.13M | ---- | ---- | ---- | ---- | 14.14%354.82M | ---- | ---- | ---- |
| -General and administrative expense | 27.02%273.27M | -39.37%215.13M | ---- | ---- | ---- | ---- | 14.14%354.82M | ---- | ---- | ---- |
| Research and development costs | 29.29%158.8M | -7.68%122.83M | ---- | ---- | ---- | ---- | 177.18%133.05M | ---- | ---- | ---- |
| Depreciation and amortization | 12.00%122.48M | -0.60%109.35M | ---- | ---- | ---- | ---- | 54.49%110.02M | ---- | ---- | ---- |
| -Depreciation | 12.00%122.48M | -0.60%109.35M | ---- | ---- | ---- | ---- | 54.49%110.02M | ---- | ---- | ---- |
| Other operating expenses | 2.66%1.45B | -8.69%1.42B | ---- | ---- | ---- | ---- | 2.73%1.55B | ---- | ---- | ---- |
| Operating profit | 313.05%942.23M | -307.65%-442.27M | 155.62%20.55M | 143.52%46.9M | -158.77%-173.5M | -638.33%-336.21M | -85.48%212.99M | -132.98%-36.94M | -120.92%-107.76M | -18.02%295.22M |
| Net non-operating interest income (expenses) | 34.87%-31.87M | 20.98%-48.94M | 39.11%-7.81M | 42.94%-11.78M | 9.53%-13.68M | -17.44%-15.67M | -37.01%-61.94M | -22.66%-12.82M | -79.57%-20.65M | -35.77%-15.12M |
| Non-operating interest income | 102.80%39.65M | 160.64%19.55M | 211.87%8.65M | 316.60%5.2M | 68.72%3.83M | 55.23%1.88M | 44.55%7.5M | 93.98%2.77M | -13.10%1.25M | 44.04%2.27M |
| Non-operating interest expense | 4.43%71.53M | -1.36%68.49M | 5.50%16.45M | -22.46%16.98M | 0.68%17.51M | 20.59%17.55M | 37.79%69.44M | 31.24%15.6M | 69.29%21.89M | 36.79%17.39M |
| Net investment income | -172.05%-96.78M | -34.53%134.32M | 2,393.02%85.39M | 55.58%-63.26M | -74.00%20.93M | -66.30%91.25M | -1.44%205.15M | -102.34%-3.72M | -314.10%-142.39M | 20,328.14%80.51M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -92.48%2.71M | 1,025.29%36.04M | -419.30%-109.32M | 380.65%77.05M | 39.57%-2.62M | 9,369.83%70.93M | 101.65%3.2M | 119.68%34.24M | -84.38%-27.45M | -2.27%-4.33M |
| Less:Other special charges | 98.13%-2.71M | -4,438.09%-145.36M | 100.02%7K | -380.65%-77.05M | -39.57%2.62M | -9,369.83%-70.93M | -102.87%-3.2M | -137.33%-34.24M | 84.38%27.45M | 2.27%4.33M |
| Less:Write off | --0 | --109.31M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Other non-operating income (expenses) | -75.51%41.83M | 143.54%170.82M | 552.42%38.26M | 125.12%75.15M | -16.51%28.13M | 154.24%29.28M | 517.73%70.14M | 8.80%-8.46M | 4,935.14%33.38M | 438.78%33.7M |
| Income before tax | 671.96%858.11M | -134.93%-150.03M | 197.70%27.07M | 146.84%124.07M | -136.09%-140.73M | -148.30%-160.43M | -69.74%429.54M | -135.84%-27.7M | -147.65%-264.87M | 16.62%389.98M |
| Income tax | -120.79%-53.77M | -32.69%258.63M | -22.53%87.57M | -44.92%76.06M | -15.71%79.96M | -60.68%15.04M | 393.77%384.24M | 130.43%113.04M | 29.10%138.08M | 89.73%94.87M |
| Net income | 323.14%911.88M | -1,002.26%-408.66M | 57.01%-60.51M | 111.91%48.01M | -174.79%-220.7M | -159.71%-175.47M | -97.08%45.29M | -131.36%-140.74M | -189.76%-402.95M | 3.77%295.1M |
| Net income continuous operations | 323.14%911.88M | -1,002.24%-408.66M | 57.01%-60.51M | 111.91%48.01M | -174.79%-220.7M | -159.71%-175.47M | -97.08%45.29M | -131.36%-140.74M | -189.76%-402.95M | 3.76%295.1M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 323.14%911.88M | -1,002.26%-408.66M | 57.01%-60.51M | 111.91%48.01M | -174.79%-220.7M | -159.71%-175.47M | -97.08%45.29M | -131.36%-140.74M | -189.76%-402.95M | 3.77%295.1M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 323.14%911.88M | -1,002.26%-408.66M | 57.01%-60.51M | 111.91%48.01M | -174.79%-220.7M | -159.71%-175.47M | -97.08%45.29M | -131.36%-140.74M | -189.76%-402.95M | 3.77%295.1M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 323.14%64.04 | -1,002.52%-28.7 | 56.98%-4.25 | 111.91%3.37 | -174.81%-15.5 | -159.69%-12.32 | -97.45%3.18 | -130.03%-9.88 | -176.47%-28.3 | -13.52%20.72 |
| Diluted earnings per share | 323.14%64.04 | -1,002.52%-28.7 | 57.00%-4.25 | 111.91%3.37 | -174.91%-15.5 | -159.69%-12.32 | -97.45%3.18 | -130.14%-9.884 | -181.59%-28.3 | -13.48%20.6902 |
| Dividend per share | 10 | 0 | 0 | 0 | 0 | 0 | -33.33%10 | -33.33%10 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |